bioRxivMolecular BiologyPreprint
Predicting the Purity of Multispecific Antibodies From Sequence Using Machine Learning: Methods and Applications
Aviva Mazurek, Athena Davis, Stephen R. ComeauiD, Kenny Tsang, Javier Rivera, Zhong-Fu Huang, John Holt, Sandeep KumariD, Srinath Kasturirangan
Abstract
Multispecific antibodies are prominent therapeutic agents, but many molecular formats and drug candidates that show promise during molecular discovery stages cannot be scaled up and developed into drugs due to inadequate developability. During the discovery stages, the selection of molecule format(s), molecule design, purity, and initial physiochemical stability testing criteria largely rely on scientists experience. Machine learning, however, can identify hidden trends in large datasets, aiding in the selection of drug candidates with improved developability. In this study, we present a machine learning approach to predict antibody purity, measured by the percentage of monomer after protein A purification. Using the amino acid sequences of variable regions, molecular formats, germlines and germline pairings, and calculated physiochemical properties as inputs, machine learning models were trained to predict the percentage of monomer for a given multispecific antibody (Figure 1). The dataset employed in this study consists of [~]500 multi-specific antibodies generated during BIs internal drug discovery programs. Our results indicate that machine learning, when applied to sequence, germline, and format data, can effectively predict antibody percentage of monomer. Incorporating this approach into high-throughput multispecific antibody screening processes can save time and resources by reducing the need to test a large subset of potentially unstable antibodies. While this study focused on percentage of monomer as a test case, similar approaches can be employed to predict other antibody properties, such as melting temperature (Tm), hydrophobicity (aHIC), and solution stability properties (AC-SINS). O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=47 SRC="FIGDIR/small/570217v1_fig1.gif" ALT="Figure 1"> View larger version (11K): org.highwire.dtl.DTLVardef@f23246org.highwire.dtl.DTLVardef@c2b81aorg.highwire.dtl.DTLVardef@1c4e59dorg.highwire.dtl.DTLVardef@1bed683_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOFigure 1C_FLOATNO Overview of ML model for predicting multispecific antibody purity from sequence, germline and format information. C_FIG
- assay: protein sequence
- research focus: benchmarking
- research focus: software / tool
- approach: machine learning (classical)
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Predicting Antibody Developability from Sequence using Machine Learning
Xingyao Chen, Thomas Dougherty, … Ian Kerman·bioRxiv·Jun 18, 2020
- PROPERMAB: an integrative framework for in silico prediction of antibody developability using machine learning
Bian Li, Shukun Luo, … Gurinder S. Atwal·mAbsPeer-reviewed·Mar 5, 2025
- A high-throughput platform for biophysical antibody developability assessment to enable AI/ML model training
Ammar Arsiwala, Rebecca Bhatt, … David W. Borhani·mAbsPeer-reviewed·Dec 2, 2025
- Predicting purification process fit of monoclonal antibodies using machine learning
Andrew J. Maier, Minjeong Cha, … Ambrose J. Williams·mAbsPeer-reviewed·Jan 9, 2025
- Unconstrained generation of synthetic antibody-antigen structures to guide machine learning methodology for real-world antibody specificity prediction
P. A. Robert, R. Akbar, … V. Greiff·bioRxiv·Jul 6, 2021
- Molecular Surface Descriptors to Predict Antibody Developability
Eliott Park, Saeed Izadi·bioRxiv·Jul 18, 2023